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Transection and devascularization procedures have been by far the most popular operations for the
treatment of oesophagogastric varices in Japan during the last two decades
1-5 and although since the new
development of endoscopic sclerotherapy during the last ten years the number of patients treated by
operation has decreased considerably, these procedures still remain the treatment of choice in many of
the surgical institutions in Japan, especially in good-risk patients with oesophagogastric varices.
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OUR EXPERIENCE
During the period January, 1964 to March, 1990, 532 patients have been treated by
transection and devascularization procedures in our department: diseases causing
portal hypertension and varices were liver cirrhosis in 381, idiopathic portal
hypertension (IPH) 104, extrahepatic portal obstruction (EHPO) in 38, schistoso-
miasis japonica in 4, Budd-Chiari syndrome in 2, and other diseases in 3.
Approximately 85% of cirrhotic patients were either cryptogenic or posthepatitic.
Mean ages of these patients were 48.6 _+ 10.9 years in cirrhosis, 48.2 _+ 12.0 years in
IPH, and 23.4_+15.8 years in EHPO (Mean+SD). Male: female ratio was
approximately 2:1. Results of non-shunting operations in patients with cirrhosis,
IPH and EHPO were analysed. Overall operative mortality was 5.0%, it was
observed only in patients with liver cirrhosis and was higher in emergency cases
(23.3%) compared to elective (3.6%) or prophy|actic(3.9%) cases.
Operative mortality was also high in Child C patients (17.1%) compared to Child
A and B patients (0% and 2.3% respectively). Long-term results in these patients
differed significantly by the nature of original diseases and severity of hepatic
deterioration. Cumulative survival rates at 5 years in patients with EHPO were
97.3%, 92.0% in IPH, and 62.4% in cirrhosis, and those at 10 years were 90.6%,
76.7%, and 32.0% respectively. Cumulative survival rates at 5 years in patients
with cirrhosis classified as Child A was 76.6%, 71.6% in Child B, and 37.4% in
Child C. Cumulative survival rates at 10 years were 54.9% in Child A, 35.5% in
Child B and 13.0% in Child C.
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Recurrent bleeding rate of non-shunting operations (including both bleeding
from recurrent varices and bleeding from peptic ulcers and hemorrhagic gastritis)
was around 20% at 10 years, irrespective of the types of operations. Postoperative
follow-up by endoscopy revealed that recurrence rate of varices after operation was
5% at one year, 16% at 2 years, 26% at 3 years, 30% at 4 years and 35% at 5 years.
Recurrence of varices was observed more often in patients with alcoholic cirrhosis
or in those with cirrhosis complicated by hepatocellular carcinoma. Recently,
recurrence of varices after these non-shunting operations have been successfully
treated by endoscopic sclerotherapy. Usually a session or two of endoscopic
injection sclerotherapy could erradicate the residual or recurrent varices. Our
experiences have clearly shown that devascularization and transection procedures
are a safe and preferable operation in patients in ChildA and B categories, and also
feasible as an emergency operation in these cases when necessary. However, these
operations are not indicated in Child C patients6. In assessing a patient’s risk for
these procedures, albumin and bilirubin levels in serum, S-GOT, S-GPT, antipyrin
clearance, ICG-15, K-ICG, prothrombin time and hepaplastin test are very
informative (Table 1).
Table 1 Indications for surgical treatment have become more strict since 1986 when technique of
sclerotherapy was established.
Indications for Surgical Treatment
Age
History
Endoscopic Findings
Clinical Symptoms
Liver Function Tests
Albumin
Bilirubin
S-GOT
S-GPT
Antipyrin Clearance
Prothrombin Time
Hepaplastin Test
ICG R- 15
K-ICG
before |986
70 year old>
history of bleeding
R-C sign(+), Fz-3, CB
Encephalopathy (--)
Ascites (--)
Cachexia (-)
2.8 g/dl<
3.5 mg/dl
200 units
200 units
0.10 ml/min/kg
50% <
50% <
40% >
0.04 min-
No severe complications
in other organs
after 986
65 year old
ditto
[ ditto ]
3.0 g/dl <
2.0 mg/dl
100 units
100 units
[ ditto ]
[ ditto ]
[ ditto ]
[ ditto ]
0.06 min
-I
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ENDOSCOPIC SCLEROTHERAPY
Endoscopic sclerotherapy has become very popular in Japan during the last several
years, and now the number of patients treated by this modality of treatment
exceeds that of those treated by operation7. A recent nation-wide survey revealed
that approximately 85% of patients with varices were treated initially by sclerother-
apy, and only 15% treated by surgery. Reasons for this drastic change are not clear,
however the following may explain some of the reasons" improvement of technical
skills and equipments of endoscopy, development of effective sclerosants, increas-
ing number of aged patients, increasing incidence of hepatocellular carcinoma in
post-hepatitic cirrhosis, increasing number of endoscopists in Japan and their
interests and enthusiasm for this modality of treatment.
We started sclerotherapy for varices in 1969 in our department and treated 169
patients in whom surgery was not indicated, namely in Child C patients, patients
complicated with unresectable hepatoma, patients with residual or recurrent
varices after operation, rejection of operation by patient, or in whom treatment
was performed as a prophylactic measure.
Cumulative survival rates of these patients were 72% at one year, 45% at 3 years,
and 34% at 5 years. Cumulative survival rate in Child A patients was 72.0% which
was not significantly different from that of non-shunting operations, but those of
Child B and C patients were much lower than those of patients treated by surgery
(Figures 1,2,3). This was partly because the sclerotherapy treated group included
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Figure 2 Cumulative survival rate in Child B patients" Non-shunting operation vs sclerotherapy.
more patients who were complicated by hepatoma. Recurrence rate of bleeding
after sclerotherapy was rather high, 22% of pfitients had at least one episode of
rebleeding by the end of one year after sclerotherapy, and rebleeding rate reached
up to 33% at 3 years. Oesophageal varices in Child C patients did not improve even
after several sessions of.sclerotherapy and patients with large caliber varices with
increased blood flow were difficult to treat by sclerotherapy, who were eventually
treated by surgery. It is rather disappointing for us surgeons that sclerotherapy has
not been successful in many of the poor risk patients in whom operation can not be
tolerated.
PROPHYLACTIC TREATMENT OF OESOPHAGOGASTRIC VARICES
Prophylactic treatment of oesophagogastric varices has been a target of controversy
among surgeons for many years, since predictability of rupture of varices has been
doubted.
Endoscopic findings, and intravariceal pressure are considered to be of signifi-
cant value in predicting variceal rupture8-11.DEVASCULARIZATION AND TRANSECTION 37
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Figure 3 Cumulative survival rate in Child C patients; Non-shunting operation vs sclerotherapy.
Correlation between Red-Color signs on endoscopy and intravariceal pressure
was also found. On the basis of Red-Color signs and prognostic blue color of
varices by endoscopy, prophylactic operation and prophylactic sclerotherapy have
been widely performed in Japan7. Only few prospective controlled studies of
prophylactic operations have been reported so far12. Mortality rate and morbidity
directly related to prophylactic treatment have been very low with non-shunting
operations and sclerotherapy.
Reports of prophylactic controlled studies with sclerotherapy are
accumulating,
13-19 but the results have not been unanimous, and therefore not
convincing.
Further study seems to be necessary before prophylactic treatment of oesopha-
geal varices can be justified.
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